Vectibix (panitumumab) 20 mg/20 mL concentrate for solution for infusion, 1 vial Colorectal cancer treatment. Targeted cancer therapy. Delivery of medications from Europe, guaranteed storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Vectibix is ??indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) with the non-mutant (wild) type RAS:

• firstly, in combination therapy with the regimen FOLFOX /FOLFOX/ or FOLFIRI /FOLFIRI/;
• from a friend to a friend combination therapy following the FOLFIRI regimen for patients who were previously treated with fluoropyrimidine-based chemotherapy (including irinotecan);
• as monotherapy varies depending on the effect after treatment with chemotherapy regimens based on fluoropyrimidine, oxaliplatin and irinotecan.

• Dozi.

  The recommended dose of Vectibix is ??6 mg/kg body weight once every two times tizhni.